Free Float 84,77 %
Shares Float 600.696,00
Shares Outstanding 708.609,00
FSD PHARMA B
Share · CA35954B4047 · HUGE · A3E2LR (XCNQ)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of FSD PHARMA B
No Price
Share Float & Liquidity
Company Profile for FSD PHARMA B Share
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.
Company Data
Name FSD PHARMA B
Company FSD Pharma Inc.
Symbol HUGE
Website
https://www.fsdpharma.com
Primary Exchange 
Frankfurt
Frankfurt
WKN A3E2LR
ISIN CA35954B4047
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Zeeshan Saeed
Country Canada
Currency EUR
Employees 0,0 T
Address 199 Bay Street, M5L 1A9 Toronto
IPO Date 2018-06-08
Stock Splits
| Date | Split |
|---|---|
| 15.08.2024 | 1:65 |
| 17.10.2019 | 1:201 |
| 16.10.2019 | 1:201 |
| 31.05.2006 | 1:500 |
Ticker Symbols
| Name | Symbol |
|---|---|
| CSE LISTED | HUGE.CN |
| Frankfurt | 0K9.F |
| NASDAQ | HUGE |
More Shares
Investors who hold FSD PHARMA B also have the following shares in their portfolio:
